The store will not work correctly when cookies are disabled.
4'-(2-Butoxyethoxy)-3-fluoro[1,1'-biphenyl]-4-carboxylic acid
ID: ALA513760
PubChem CID: 25259265
Max Phase: Preclinical
Molecular Formula: C19H21FO4
Molecular Weight: 332.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCOCCOc1ccc(-c2ccc(C(=O)O)c(F)c2)cc1
Standard InChI: InChI=1S/C19H21FO4/c1-2-3-10-23-11-12-24-16-7-4-14(5-8-16)15-6-9-17(19(21)22)18(20)13-15/h4-9,13H,2-3,10-12H2,1H3,(H,21,22)
Standard InChI Key: JXQRCYPIISFGII-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
4.3440 -15.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0603 -15.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7726 -15.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7726 -14.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0603 -13.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3440 -14.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6275 -15.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9154 -15.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2031 -15.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2031 -16.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9154 -16.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6275 -16.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4890 -13.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4890 -13.0409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2053 -14.2763 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4890 -15.5158 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4867 -16.7512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7745 -16.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0581 -16.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6582 -16.3408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3705 -16.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0869 -16.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8033 -16.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5114 -16.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
1 7 1 0
13 14 2 0
13 15 1 0
4 13 1 0
3 16 1 0
18 19 1 0
17 18 1 0
21 22 1 0
22 23 1 0
23 24 1 0
20 21 1 0
19 20 1 0
10 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.37 | Molecular Weight (Monoisotopic): 332.1424 | AlogP: 4.39 | #Rotatable Bonds: 9 |
Polar Surface Area: 55.76 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.32 | CX Basic pKa: ┄ | CX LogP: 4.54 | CX LogD: 1.12 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.69 | Np Likeness Score: -0.92 |
References
1. Lund BW, Knapp AE, Piu F, Gauthier NK, Begtrup M, Hacksell U, Olsson R.. (2009) Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands., 52 (6): [PMID:19239230] [10.1021/jm801532e] |